Comparing Migraine Severity for AVP‐825 vs. Oral Sumatriptan Using Bifactor Analysis: Results of the COMPASS Study

Drs. McGinley and Wirth’s Platform Presentation (#IOR10) will be held on Saturday, June 10^th at 9:30AM in the at AHS 2017 in Boston, MA.